Form 144 Bioventus Inc. For: 4 December
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bioventus Inc (BVS)
Bioventus Inc stock price live, this page displays NASDAQ BVS stock exchange data. View the BVS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bioventus Inc real time stock price chart below.
What Is the Bioventus Inc Stock Price Today?
The Bioventus Inc stock price today is 8.020.
What Is the Stock Symbol for Bioventus Inc?
The stock symbol for Bioventus Inc is "BVS."
What Stock Exchange Does Bioventus Inc Trade On?
Bioventus Inc is listed and trades on the NASDAQ stock exchange.
Is Bioventus Inc a Good Stock to Buy?
Determining whether Bioventus Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BVS quote. (ISIN: US09075A1088)
What Is the Bioventus Inc Stock Price Today?
The Bioventus Inc stock price today is 8.020.
What Is the Stock Symbol for Bioventus Inc?
The stock symbol for Bioventus Inc is "BVS."
What Stock Exchange Does Bioventus Inc Trade On?
Bioventus Inc is listed and trades on the NASDAQ stock exchange.
Is Bioventus Inc a Good Stock to Buy?
Determining whether Bioventus Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BVS quote. (ISIN: US09075A1088)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.010
8.270
52 wk Range
5.810
11.250
BVS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.0108.270
52 wk Range
5.81011.250
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BVS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
15.000
Upside
+87.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 8K Bioventus Inc For: 17 November
- Investing.com
- Form 144 Bioventus Inc. For: 4 December
- Investing.com
- Form 8K Bioventus Inc For: 17 November
- Investing.com
- Form 144 Bioventus Inc. For: 7 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Bioventus Inc Company Profile
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise of various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides nexus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company’s restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system; and Talisman pulse generator and receiver for peripheral nerve stimulation. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina.
Bioventus Inc Earnings Call Summary for Q3/2025
- Bioventus Q3 2025 reported adjusted EPS of $0.15, exceeding forecasts by 36.36%, with revenue reaching $139 million despite a 2.29% stock decline in premarket trading.
- The company achieved 8% organic growth, with adjusted EBITDA increasing 13% to $27 million and margin expansion of 220 basis points to 19%.
- Bioventus reaffirmed its 2025 guidance, projecting 6-8% organic revenue growth and adjusted EBITDA between $112-116 million while targeting $1 billion in high-growth business.
- CEO Rob Claypoole announced a 'new phase of transformation' focused on expanding Peripheral Nerve Stimulation and Platelet-Rich Plasma offerings, expected to contribute 200 basis points of growth in 2026.
- Cash from operations nearly tripled to $30 million year-over-year, while the company aims for 100 basis points margin expansion through commercial growth in the PNS market.
Last Updated: 2025-11-04, 09:36 a/m
Read Full TranscriptCompare BVS to Peers and Sector
Metrics to compare | BVS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBVSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 52.8x | −3.7x | −0.6x | |
PEG Ratio | 0.43 | 0.00 | 0.00 | |
Price/Book | 3.2x | 1.3x | 2.6x | |
Price / LTM Sales | 1.0x | 2.1x | 3.4x | |
Upside (Analyst Target) | 87.0% | 33.2% | 42.0% | |
Fair Value Upside | Unlock | 9.4% | 5.0% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 15.000
(+87.03% Upside)
Earnings
Latest Release
Nov 04, 2025
EPS / Forecast
0.15 / 0.11
Revenue / Forecast
138.70M / 137.65M
People Also Watch
FAQ
What Is the Bioventus (BVS) Stock Price Today?
The Bioventus stock price today is 8.020
What Stock Exchange Does Bioventus Trade On?
Bioventus is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Bioventus?
The stock symbol for Bioventus is "BVS."
What Is the Bioventus Market Cap?
As of today, Bioventus market cap is 537.15M.
What Is Bioventus's Earnings Per Share (TTM)?
The Bioventus EPS (TTM) is 0.15.
When Is the Next Bioventus Earnings Date?
Bioventus will release its next earnings report on Mar 17, 2026.
From a Technical Analysis Perspective, Is BVS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Bioventus Stock Split?
Bioventus has split 0 times.
How Many Employees Does Bioventus Have?
Bioventus has 950 employees.
What is the current trading status of Bioventus (BVS)?
As of Jan 24, 2026, Bioventus (BVS) is trading at a price of 8.020, with a previous close of 8.150. The stock has fluctuated within a day range of 8.010 to 8.270, while its 52-week range spans from 5.810 to 11.250.
What Is Bioventus (BVS) Price Target According to Analysts?
The average 12-month price target for Bioventus is USD15.000, with a high estimate of USD15 and a low estimate of USD15. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +87.03% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.